Research using in vivo single-cell CRISPR has shed light on the role of distinct TNF programmes in tumour evolution. The study's findings may have implications for understanding cancer development, although the specifics of the discovery are not clear from the available information. The research appears to be part of a broader effort to apply single-cell analysis and CRISPR technology to various fields, including cancer and disease research.